These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1540 related items for PubMed ID: 31285768

  • 21. Allicin Inhibits Proliferation and Invasion in Vitro and in Vivo via SHP-1-Mediated STAT3 Signaling in Cholangiocarcinoma.
    Chen H, Zhu B, Zhao L, Liu Y, Zhao F, Feng J, Jin Y, Sun J, Geng R, Wei Y.
    Cell Physiol Biochem; 2018; 47(2):641-653. PubMed ID: 29794468
    [Abstract] [Full Text] [Related]

  • 22. Discovery of VEGFR-2 inhibitors exerting significant anticancer activity against CD44+ and CD133+ cancer stem cells (CSCs): Reversal of TGF-β induced epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma.
    Modi SJ, Kulkarni VM.
    Eur J Med Chem; 2020 Dec 01; 207():112851. PubMed ID: 33002846
    [Abstract] [Full Text] [Related]

  • 23. Scorpion inhibits epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Yan YQ, Xie J, Wang JF, Shi ZF, Zhang X, Du YP, Zhao XC.
    Exp Biol Med (Maywood); 2018 Apr 01; 243(7):645-654. PubMed ID: 29486578
    [Abstract] [Full Text] [Related]

  • 24. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.
    Rajendran P, Li F, Shanmugam MK, Vali S, Abbasi T, Kapoor S, Ahn KS, Kumar AP, Sethi G.
    J Cell Physiol; 2012 May 01; 227(5):2184-95. PubMed ID: 21792937
    [Abstract] [Full Text] [Related]

  • 25. Lipopolysaccharide supports maintaining the stemness of CD133(+) hepatoma cells through activation of the NF-κB/HIF-1α pathway.
    Lai FB, Liu WT, Jing YY, Yu GF, Han ZP, Yang X, Zeng JX, Zhang HJ, Shi RY, Li XY, Pan XR, Li R, Zhao QD, Wu MC, Zhang P, Liu JF, Wei LX.
    Cancer Lett; 2016 Aug 10; 378(2):131-41. PubMed ID: 27208741
    [Abstract] [Full Text] [Related]

  • 26. Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells.
    Yang J, Cai X, Lu W, Hu C, Xu X, Yu Q, Cao P.
    Cancer Lett; 2013 Jan 28; 328(2):243-51. PubMed ID: 23032719
    [Abstract] [Full Text] [Related]

  • 27. Arsenic trioxide: marked suppression of tumor metastasis potential by inhibiting the transcription factor Twist in vivo and in vitro.
    Wang GZ, Zhang W, Fang ZT, Zhang W, Yang MJ, Yang GW, Li S, Zhu L, Wang LL, Zhang WS, Liu R, Qian S, Wang JH, Qu XD.
    J Cancer Res Clin Oncol; 2014 Jul 28; 140(7):1125-36. PubMed ID: 24756364
    [Abstract] [Full Text] [Related]

  • 28. Peroxiredoxin II Is Essential for Maintaining Stemness by Redox Regulation in Liver Cancer Cells.
    Kwon T, Bak Y, Park YH, Jang GB, Nam JS, Yoo JE, Park YN, Bak IS, Kim JM, Yoon DY, Yu DY.
    Stem Cells; 2016 May 28; 34(5):1188-97. PubMed ID: 26866938
    [Abstract] [Full Text] [Related]

  • 29. Arsenic trioxide inhibits EMT in hepatocellular carcinoma by promoting lncRNA MEG3 via PKM2.
    Fan Z, He J, Fu T, Zhang W, Yang G, Qu X, Liu R, Lv L, Wang J.
    Biochem Biophys Res Commun; 2019 Jun 11; 513(4):834-840. PubMed ID: 31003765
    [Abstract] [Full Text] [Related]

  • 30. Anticancer activity of dietary xanthone α-mangostin against hepatocellular carcinoma by inhibition of STAT3 signaling via stabilization of SHP1.
    Zhang H, Tan YP, Zhao L, Wang L, Fu NJ, Zheng SP, Shen XF.
    Cell Death Dis; 2020 Jan 24; 11(1):63. PubMed ID: 31980595
    [Abstract] [Full Text] [Related]

  • 31. Notch Inhibitor PF-03084014 Inhibits Hepatocellular Carcinoma Growth and Metastasis via Suppression of Cancer Stemness due to Reduced Activation of Notch1-Stat3.
    Wu CX, Xu A, Zhang CC, Olson P, Chen L, Lee TK, Cheung TT, Lo CM, Wang XQ.
    Mol Cancer Ther; 2017 Aug 24; 16(8):1531-1543. PubMed ID: 28522590
    [Abstract] [Full Text] [Related]

  • 32. Polyphyllin VII as a Potential Drug for Targeting Stemness in Hepatocellular Cancer via STAT3 Signaling.
    Xu L, Chen Z, Wang Y, Li Y, Wang Z, Li F, Xi X.
    Curr Cancer Drug Targets; 2023 Aug 24; 23(4):325-331. PubMed ID: 36284387
    [Abstract] [Full Text] [Related]

  • 33. Epithelial to mesenchymal transition is involved in ethanol promoted hepatocellular carcinoma cells metastasis and stemness.
    Chen D, Yu D, Wang X, Liu Y, He Y, Deng R, Jiang Y, Zhang F, Liu Y, Xu M, Li J, Luo J, Wang S.
    Mol Carcinog; 2018 Oct 24; 57(10):1358-1370. PubMed ID: 30295962
    [Abstract] [Full Text] [Related]

  • 34. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX, Qi Y, Zhang J, Liu Y, Xu WH, Xu J, Hu HG, Wu QY, Wang Y, Zhang JP.
    Oncotarget; 2016 Nov 29; 7(48):79544-79556. PubMed ID: 27783993
    [Abstract] [Full Text] [Related]

  • 35. A novel obatoclax derivative, SC-2001, induces apoptosis in hepatocellular carcinoma cells through SHP-1-dependent STAT3 inactivation.
    Chen KF, Su JC, Liu CY, Huang JW, Chen KC, Chen WL, Tai WT, Shiau CW.
    Cancer Lett; 2012 Aug 01; 321(1):27-35. PubMed ID: 22465052
    [Abstract] [Full Text] [Related]

  • 36. Brusatol inhibits laryngeal cancer cell proliferation and metastasis via abrogating JAK2/STAT3 signaling mediated epithelial-mesenchymal transition.
    Zhou J, Hou J, Wang J, Wang J, Gao J, Bai Y.
    Life Sci; 2021 Nov 01; 284():119907. PubMed ID: 34453950
    [Abstract] [Full Text] [Related]

  • 37. Protopanaxadiol inhibits epithelial-mesenchymal transition of hepatocellular carcinoma by targeting STAT3 pathway.
    Yang L, Zhang XY, Li K, Li AP, Yang WD, Yang R, Wang P, Zhao ZH, Cui F, Qin Y, Yang JH, Tao HL, Sun T, Chen S, Yu PH, Liu HJ, Yang C.
    Cell Death Dis; 2019 Aug 20; 10(9):630. PubMed ID: 31431619
    [Abstract] [Full Text] [Related]

  • 38. Cetylpyridinium chloride inhibits hepatocellular carcinoma growth and metastasis through regulating epithelial-mesenchymal transition and apoptosis.
    Cai K, Fang Y, Zhang Y, Liu J, Ye Q, Ding L, Cai X.
    PLoS One; 2024 Aug 20; 19(9):e0310391. PubMed ID: 39302935
    [Abstract] [Full Text] [Related]

  • 39. RFX-1-dependent activation of SHP-1 inhibits STAT3 signaling in hepatocellular carcinoma cells.
    Su JC, Chiang HC, Tseng PH, Tai WT, Hsu CY, Li YS, Huang JW, Ko CH, Lin MW, Chu PY, Liu CY, Chen KF, Shiau CW.
    Carcinogenesis; 2014 Dec 20; 35(12):2807-14. PubMed ID: 25322871
    [Abstract] [Full Text] [Related]

  • 40. Cantharidin treatment inhibits hepatocellular carcinoma development by regulating the JAK2/STAT3 and PI3K/Akt pathways in an EphB4-dependent manner.
    Zhu M, Shi X, Gong Z, Su Q, Yu R, Wang B, Yang T, Dai B, Zhan Y, Zhang D, Zhang Y.
    Pharmacol Res; 2020 Aug 20; 158():104868. PubMed ID: 32407961
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 77.